HRT Financial’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

HRT Financial’s Portfolio NVOS Stock Details NVOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-93,576	Closed	-$26K	–	3499
2024 Q3	$26K	Buy	+93,576	New	+$43.7K	﹤0.01%	2167
2023 Q1	–	Sell	-4,345	Closed	-$8K	–	3431
2022 Q4	$8K	Buy	+4,345	New	+$14.9K	﹤0.01%	2244

Other funds holding NVOS

ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

HRT Financial's NVOS Position: Q4 2024 in Review

HRT Financial sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 93,576 shares — an estimated $26K sold.

HRT Financial first reported a position in NVOS in Q4 2022 and held it in 2 quarters. The position peaked at $26K in Q3 2024. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

HRT Financial reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
HRT Financial sold 93,576 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $26K.
HRT Financial first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
HRT Financial's Novo Integrated Sciences, Inc. Common Stock position peaked at $26K in Q3 2024.
1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.